Over the past 10 years adoptive immunotherapieshave been developed for cancer treatment. Cytotoxic Tlymphocytes (CTL) play a major role in host antitumorimmune response. The perforin and Fas ligand (Fas-L)pathways whi...Over the past 10 years adoptive immunotherapieshave been developed for cancer treatment. Cytotoxic Tlymphocytes (CTL) play a major role in host antitumorimmune response. The perforin and Fas ligand (Fas-L)pathways which were two major mechanisms are res-ponsible for tumor cell death by CTLs. A major obstacleto the application of adoptive imunotherapy in thetreatment of human malignancy has been the inability展开更多
文摘Over the past 10 years adoptive immunotherapieshave been developed for cancer treatment. Cytotoxic Tlymphocytes (CTL) play a major role in host antitumorimmune response. The perforin and Fas ligand (Fas-L)pathways which were two major mechanisms are res-ponsible for tumor cell death by CTLs. A major obstacleto the application of adoptive imunotherapy in thetreatment of human malignancy has been the inability
